Making a difference worldwide
The LEO Foundation is one of Denmark’s largest commercial foundations. Established in 1984, our main objective is to ensure the long-term continuation and success of the global, research-based pharmaceutical company LEO Pharma. The LEO Foundation is the sole shareholder of LEO Pharma and is independent from heirs, outside shareholders, and other interests.
The LEO Foundation also provides philanthropic grants to some of the world’s leading scientists within skin research, combating the impact of skin diseases. Our mission is to support the best international research in skin diseases and make Denmark a global beacon for skin research.
In addition to the ownership of LEO Pharma, the LEO Foundation owns financial assets of around DKK 14,5 billion. The main objectives of the investments are to provide capability to support LEO Pharma’s long-term continuation and strategic development, as well as provide funds for the Foundation’s philanthropic activities.